/
/
/

Alpa Laboratories Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018
₹24 Cr₹31 Cr₹29 Cr₹26 Cr₹19 Cr₹40 Cr₹26 Cr₹25 Cr₹21 Cr₹24 Cr₹27 Cr₹32 Cr₹21 Cr₹29 Cr₹27 Cr₹14 Cr₹22 Cr₹25 Cr₹29 Cr₹26 Cr₹32 Cr₹25 Cr₹33 Cr₹24 Cr₹16 Cr₹18 Cr₹24 Cr₹24 Cr₹20 Cr₹19 Cr₹26 Cr₹16 Cr
₹6 Cr-₹16 L₹91 L₹3 Cr₹12 Cr₹2 Cr₹9 Cr₹7 Cr₹5 Cr₹4 Cr₹4 Cr₹3 Cr₹5 Cr-₹69 L₹3 Cr₹6 Cr₹2 Cr₹2 Cr₹2 Cr₹3 Cr₹4 Cr₹66 L₹1 Cr₹27 L₹2 Cr₹78 L₹1 Cr₹27 L₹71 L₹2 Cr₹59 L₹1 Cr
₹30 Cr₹31 Cr₹30 Cr₹29 Cr₹31 Cr₹42 Cr₹35 Cr₹32 Cr₹27 Cr₹28 Cr₹31 Cr₹35 Cr₹27 Cr₹28 Cr₹30 Cr₹20 Cr₹24 Cr₹27 Cr₹32 Cr₹29 Cr₹36 Cr₹26 Cr₹34 Cr₹24 Cr₹18 Cr₹19 Cr₹25 Cr₹24 Cr₹21 Cr₹21 Cr₹27 Cr₹17 Cr
₹29 Cr₹28 Cr₹28 Cr₹29 Cr₹19 Cr₹40 Cr₹26 Cr₹22 Cr₹21 Cr₹21 Cr₹26 Cr₹30 Cr₹21 Cr₹20 Cr₹25 Cr₹20 Cr₹21 Cr₹25 Cr₹26 Cr₹23 Cr₹29 Cr₹24 Cr₹31 Cr₹23 Cr₹15 Cr₹20 Cr₹23 Cr₹23 Cr₹20 Cr₹23 Cr₹24 Cr₹17 Cr
₹2 Cr₹3 Cr₹2 Cr₹82 L₹12 Cr₹3 Cr₹10 Cr₹10 Cr₹6 Cr₹7 Cr₹6 Cr₹6 Cr₹6 Cr₹9 Cr₹5 Cr₹64 L₹3 Cr₹3 Cr₹6 Cr₹6 Cr₹7 Cr₹2 Cr₹4 Cr₹1 Cr₹4 Cr-₹40 L₹3 Cr₹1 Cr₹2 Cr-₹50 L₹3 Cr₹1 Cr
₹11 L₹15 L₹3 L₹3 L₹5 L₹2 L₹9 L₹5 L₹5 L₹29 L₹2 L₹2 L₹5 L₹4 L₹7 L₹8 L₹3 L₹5 L₹8 L₹6 L₹4 L₹80,000₹2 L₹5 L₹2 L₹3 L₹3 L₹5 L₹9 L₹7 L₹10 L₹22 L
₹98 L₹3 Cr₹2 Cr₹11 L₹12 Cr₹2 Cr₹9 Cr₹10 Cr₹5 Cr₹7 Cr₹5 Cr₹6 Cr₹6 Cr₹8 Cr₹5 Cr₹20 L₹3 Cr₹2 Cr₹5 Cr₹6 Cr₹6 Cr₹2 Cr₹4 Cr₹39 L₹3 Cr-₹1 Cr₹3 Cr₹39 L₹1 Cr-₹1 Cr₹2 Cr₹20 L
₹98 L₹1 Cr₹2 Cr₹11 L₹12 Cr-₹2 Cr₹9 Cr₹8 Cr₹5 Cr₹4 Cr₹5 Cr₹6 Cr₹6 Cr₹5 Cr₹5 Cr₹20 L₹3 Cr-₹3 Cr₹5 Cr₹6 Cr₹6 Cr-₹2 Cr₹4 Cr₹39 L₹3 Cr-₹2 Cr₹3 Cr₹39 L₹1 Cr-₹3 Cr₹2 Cr₹20 L

Share Price Live Stats

Open (₹)64.00
Volume (₹)6,717.00
High (₹)64.00
Upper Circuit75.96
Low (₹)62.05
Lower Circuit50.64
Prev Close63.30
52W High (₹)99.00
Price63.42
52W Low (₹)46.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)134.41 Cr
Div. Yield (%)0.00
PE Ratio30.70
Debt to Equity0.00
Price to Book1.28
Book Value81.48
EPS (TTM)2.08
Face Value10.00
ROE (%)12.06

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
ALPANSE
LTP
1W Low
1W High
Market cap (₹)
1899.4-20.6 (-1.07%)
1896.80
1984.80
4,56,833Cr
9132.5-106.5 (-1.15%)
9087
9467
2,45,426Cr
4841.5-208.5 (-4.13%)
4823
5066
1,87,320Cr
1129.3-61.7 (-5.18%)
1125.10
1187
1,13,217Cr
1380.1-43.4 (-3.05%)
1376
1426.10
1,12,212Cr
1843.1-95.4 (-4.92%)
1811.70
1949
1,01,155Cr
2109-62.5 (-2.88%)
2107.20
2192
97,626Cr
2330.9-52 (-2.18%)
2327.30
2419.20
96,859Cr
1157.7-20.3 (-1.72%)
1154.40
1179.90
96,406Cr
1653.4+8.1 (0.49%)
1622.60
1717
93,614Cr
63.42-0.35 (-0.55%)
61
65
134Cr

Key Highlights of Alpa Laboratories Ltd’s P&L

In 2025-03-31, Alpa Laboratories Ltd reported total revenue of ₹135.8Cr, compared with ₹123.63Cr in 2024-03-31, reflecting Alpa Laboratories Ltd turnover.

Depreciation was ₹2.2Cr and finance costs were ₹23.18Lakh in 2025-03-31

Profit Before Tax (PBT) has been ₹25.67Cr in 2025-03-31 as compared to ₹20.68Cr in 2024-03-31.

Net Profit (PAT) was ₹19.5Cr in 2025-03-31 compared with ₹16.78Cr in 2024-03-31.

Earnings per share (EPS) were ₹9.27 in 2025-03-31, compared with ₹7.97 in 2024-03-31.